{
  "actions": [
    {
      "acted_at": "2019-05-16T15:21:54-04:00",
      "action_code": "H32111",
      "how": "by voice vote",
      "references": [],
      "result": "pass",
      "text": "On agreeing to the DeSaulnier amendment (A005) Agreed to by voice vote.",
      "type": "vote",
      "vote_type": "vote",
      "where": "h"
    },
    {
      "acted_at": "2019-05-16T15:15:59-04:00",
      "action_code": "H3A100",
      "references": [
        {
          "reference": "CR H3878-3879",
          "type": "consideration"
        },
        {
          "reference": "CR H3878",
          "type": "text"
        }
      ],
      "text": "Amendment (A005) offered by Mr. DeSaulnier.",
      "type": "action"
    },
    {
      "acted_at": "2019-05-16T15:15:59-04:00",
      "action_code": "71500",
      "references": [],
      "text": "House amendment offered/reported by: Amendment (A005) offered by Mr. DeSaulnier.",
      "type": "action"
    },
    {
      "acted_at": "2019-05-16T15:21:54-04:00",
      "action_code": "72000",
      "references": [],
      "text": "House amendment agreed to: On agreeing to the DeSaulnier amendment (A005) Agreed to by voice vote.",
      "type": "action"
    },
    {
      "acted_at": "2019-05-16T15:21:54-04:00",
      "action_code": "76000",
      "references": [],
      "text": "Amendment agreed to Committee of the Whole",
      "type": "action"
    },
    {
      "acted_at": "2019-05-16",
      "action_code": "71000",
      "references": [],
      "text": "House amendment offered",
      "type": "action"
    }
  ],
  "amendment_id": "hamdt224-116",
  "amendment_type": "hamdt",
  "amends_amendment": null,
  "amends_bill": {
    "bill_id": "hr987-116",
    "bill_type": "hr",
    "congress": 116,
    "number": 987
  },
  "amends_treaty": null,
  "chamber": "h",
  "congress": "116",
  "description": "An amendment numbered 5 printed in House Report 116-61 to Commission a study by the National Academy of Medicine into the amount of federal funding and research used in the development of drugs by pharmaceutical companies, and to put measures in place to curb excessive drug costs.",
  "introduced_at": "2019-05-16",
  "number": 224,
  "purpose": "An amendment numbered 5 printed in House Report 116-61 to Commission a study by the National Academy of Medicine into the amount of federal funding and research used in the development of drugs by pharmaceutical companies, and to put measures in place to curb excessive drug costs.",
  "sponsor": {
    "bioguide_id": "D000623",
    "district": "11",
    "name": "DeSaulnier, Mark",
    "state": "CA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "pass",
  "status_at": "2019-05-16T15:21:54-04:00",
  "updated_at": "2022-02-08T22:55:11Z"
}